AZ Symbicort reduces rate of asthma attacks
The results showed a a 51% reduction in the rate of annual asthma exacerbations compared to albuterol.
Read More
Tag: Turbuhaler
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
